News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
InSysBio Extends Collaboration with discoveric bio alpha to Support Alzheimer's Antibody Development
Thursday, June 26, 2025InSysBio a global leader in Quantitative Systems Pharmacology QSP modelling has announced the extension of its partnership with discoveric bio alpha a biotechnology company developing nextgeneration antibody technologies
Fortrea Partners with Emery Pharma to Support FDA-Regulated Drug-Drug Interaction Studies Involving Rifampin
Wednesday, June 25, 2025Fortreaa leading global contract research organisation CRO has entered into a strategic partnership with Emery Pharma a specialist CRO offering analytical and bioanalytical testing under current Good Manufacturing Practices
Quoin Pharmaceuticals Receives FDA Rare Paediatric Disease Designation for QRX003 in Netherton Syndrome
Wednesday, June 25, 2025Quoin Pharmaceuticals Ltd a latestage clinical pharmaceutical company focused on rare and orphan conditions has been granted Rare Paediatric Disease RPD Designation by the US Food and Drug Administration FDA for its lead product candidate QRX for the...
Revolution Medicines Receives FDA Breakthrough Therapy Designation for Daraxonrasib in Advanced Pancreatic Cancer with KRAS G12 Mutations
Tuesday, June 24, 2025Revolution Medicines Inca latestage clinical oncology firm focused on targeted therapies for RASdriven cancers has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation
DATROWAY® Approved in the U.S. as First TROP2-Directed Treatment for Advanced EGFR-Mutated Lung Cancer
Tuesday, June 24, 2025DATROWAY datopotamab deruxtecandlnk has received accelerated approval in the United States for the treatment of adults with locally advanced or metastatic nonsmall cell lung cancer NSCLC harbouring EGFR mutations
Archeus Technologies Receives FDA Clearance for Investigational Prostate Cancer Therapy ART-101
Saturday, June 21, 2025Archeus Technologies a company focused on developing radiopharmaceutical treatments for cancer has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for ART
Incyte Gains FDA Approval for Monjuvi® in Follicular Lymphoma Treatment
Friday, June 20, 2025Incyte has received approval from the US Food and Drug Administration FDA for Monjuvi tafasitamabcxix in combination with rituximab and lenalidomide for use in adults with relapsed or refractory follicular lymphoma
RyboDyn Joins Lilly Gateway Labs to Advance Novel Immunotherapies Targeting the Dark Proteome
Friday, June 20, 2025RyboDyn Inc a biotechnology company focused on developing new immunotherapies aimed at the dark proteome has been selected to join Lilly Gateway Labs LGL in San Diego Operated in partnership
Advarra Forms AI Council with Life Sciences Experts to Promote Responsible Use of Artificial Intelligence in Clinical Trials
Thursday, June 19, 2025Advarra a leader in clinical research technology and regulatory review has launched the Council for Responsible Use of AI in Clinical Trials This newly formed group brings together experts from the life sciences industry to set standards
FDA Grants Orphan Drug Designation to Medicovestor’s Innovative ADC for Pancreatic Cancer
Wednesday, June 18, 2025Medicovestor Inc a biotechnology company focused on the development of advanced antibodydrug conjugates ADCs has received Orphan Drug Designation ODD from the US Food and Drug Administration
